Olema Pharmaceuticals, Inc.
NASDAQOLMA heads into a defining two-week stretch carrying its heaviest short interest in months, a freshly beaten Q1 print, and a key oncology conference on the horizon — all while the stock trades down 13% over the past month at $13.97. The most striking development in OLMA's positioning is the rapid build in short interest over the past six weeks. Short interest as a percentage of…
Snapshot as of 28 Jun 2026
OLMA heads into a defining two-week stretch carrying its heaviest short interest in months, a freshly beaten Q1 print, and a key oncology conference on the horizon — all while the stock trades down 13% over the past…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for OLMA — free to start on ORTEX.
Sign up for free →Open OLMA on ORTEX